BRCA1 and prostate carcinoma: To explore the applicability of OFD1 inhibition in other BRCA-associated cancer types with BRCA1/2 wild-type genotypes, we generated OFD1-inducible knockdown cell lines in MDA-MB231 breast cancer cells, PC3 prostate cancer cells, and A2780 ovarian cancer cells.